Farxiga vs Ozempic: SGLT2 vs GLP-1 Comparison (Weight Loss, A1C, Cost)
Dapagliflozin (Farxiga) and semaglutide (Ozempic) are both medications used to treat type 2 diabetes, yet they work through entirely different pharmacological pathways. Farxiga is an SGLT2 inhibitor an oral medication that lowers blood glucose levels by blocking glucose reabsorption in the kidneys, causing sugar to be eliminated through urine. Ozempic is a GLP-1 receptor agonist […]
